Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin

Arti Shukla(University of Vermont), Brooke T. Mossman(University of Vermont)
Molecular Cancer
January 1, 2010
Cited by 79


Related Papers